anmelden
FTSE All-Share
5.509,65
PKT
-11,30
PKT
-0,20
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 15.01.24 | Unilever Sell | UBS AG | |
| 15.01.24 | National Grid Buy | Deutsche Bank AG | |
| 15.01.24 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
| 12.01.24 | Vodafone Group Equal Weight | Barclays Capital | |
| 12.01.24 | Glencore Equal Weight | Barclays Capital | |
| 12.01.24 | Rio Tinto Overweight | Barclays Capital | |
| 12.01.24 | Glencore Buy | Goldman Sachs Group Inc. | |
| 12.01.24 | Rio Tinto Buy | Goldman Sachs Group Inc. | |
| 11.01.24 | Glencore Buy | Deutsche Bank AG | |
| 11.01.24 | Rio Tinto Buy | Deutsche Bank AG | |
| 10.01.24 | Diageo Underperform | RBC Capital Markets | |
| 10.01.24 | BAT Neutral | JP Morgan Chase & Co. | |
| 10.01.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 10.01.24 | GSK Buy | Deutsche Bank AG | |
| 10.01.24 | Diageo Neutral | JP Morgan Chase & Co. | |
| 09.01.24 | GSK Equal Weight | Barclays Capital | |
| 09.01.24 | GSK Equal Weight | Barclays Capital | |
| 09.01.24 | GSK Sell | UBS AG | |
| 09.01.24 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.24 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 08.01.24 | Diageo Outperform | Bernstein Research | |
| 08.01.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 08.01.24 | Rio Tinto Neutral | UBS AG | |
| 08.01.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 08.01.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 08.01.24 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 08.01.24 | HSBC Buy | Jefferies & Company Inc. | |
| 05.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 04.01.24 | BP Overweight | Barclays Capital | |
| 04.01.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 04.01.24 | BP Outperform | RBC Capital Markets | |
| 04.01.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 03.01.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 03.01.24 | AstraZeneca Overweight | Barclays Capital | |
| 03.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.01.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 03.01.24 | GSK Buy | Jefferies & Company Inc. |